GlassScriptPhysician profile
Donald J Maddack
NPI 1013911031
$9,076.16
in general payments reported to CMS, 2019-2025
44 companies · $1,008 in 2025
The $1,008 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,787 · 2020: $1,022 · 2021: $759 · 2022: $1,129 · 2023: $1,600 · 2024: $1,772 · 2025: $1,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,379.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,229.47 | 2019-2025 | |
| Lilly USA, LLC | $1,051.81 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $1,019.52 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $766.99 | 2019-2025 | Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $622.09 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $610.80 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Exact Sciences Corporation | $496.39 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Allergan, INC. | $477.37 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $458.76 | 2019-2021 | |
| Amgen INC. | $347.98 | 2022-2025 | Repatha, Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $277.34 | 2021-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $178.56 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $147.37 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.72 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $139.82 | 2019-2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Maddack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.